ChromaDex (CDXC) Misses Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. CMG
8. KLAC
9. BIIB
10. ETSY

Go back to ChromaDex (CDXC) Misses Q3 EPS by 3c

ChromaDex Corporation Reports Third Quarter 2018 Financial Results

November 7, 2018 4:01 PM EST

- Third Quarter 2018 Net Revenues Increased by 33% to $8.1 Million -

Third Quarter 2018 Highlights vs. Third Quarter 2017

Net sales up 33%, fueled by growth of TRU NIAGEN®, which increased by 97%;TRU NIAGEN sales at 84% of NIAGEN-related sales, up from 60%Gross profit as a percentage of net sales improved by 580 basis points to 53.7%;Launched TRU NIAGEN PRO (60ct, 300mg per capsule), the highest dose of NR in a single capsule;Earned certification from NSF International Certified for Sport program; andSigned MOU for creation of a... More